J1741 HCPCS Level II code: Injection, ibuprofen, 100 mg
J1741 is the HCPCS code for “Injection, ibuprofen, 100 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1741Injection, ibuprofen, 100 mg
Short description: Ibuprofen injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J1741 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2013
Where J1741 sits
- 1J codesDrugs administered other than orally
- 2Active code J1741Injection, ibuprofen, 100 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1741 mean?
J1741 is the HCPCS code for “Injection, ibuprofen, 100 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1741?
CMS lists J1741’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1741
All J codesJ1729Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mgJ1730Injection, diazoxide, up to 300 mgJ1736Injection, meloxicam (delova), 1 mgJ1737Injection, meloxicam (azurity), 1 mgJ1738Injection, meloxicam, 1 mgJ1740Injection, ibandronate sodium, 1 mgJ1742Injection, ibutilide fumarate, 1 mgJ1743Injection, idursulfase, 1 mgJ1744Injection, icatibant, 1 mgJ1745Injection, infliximab, excludes biosimilar, 10 mgJ1746Injection, ibalizumab-uiyk, 10 mgJ1747Injection, spesolimab-sbzo, 1 mg